A Cross-sectional Study Looking at the Effect of Radiotherapy on Carotid Intima-medial Thickness in Head and Neck Cancer
Some patients with head and neck cancer or benign tumours of the head and neck receive radiotherapy to their neck as part of their treatment. The carotid arteries are often included in the radiotherapy as collateral structures. There is some evidence to show that radiotherapy to these blood vessels can result in thickening of the artery walls some years after treatment and increased risk of stroke or TIA in the future.
Current research is now aimed towards detecting radiotherapy-related changes to the carotid arteries at an earlier stage and towards using new radiotherapy techniques to avoid treating these blood vessels if possible. The question of whether or not the use of preventive medicines like aspirin and cholesterol-lowering tablets helps to reverse this process is currently unanswered.
The aim of this study is to measure the thickness (intima-medial thickness) of irradiated carotid artery walls and compare this to unirradiated arteries. There are many other causes for thickening of arteries (such as high blood pressure, high cholesterol levels and diabetes) and these may affect the ability to measure the effect of radiotherapy change to the artery wall. In order to address this, it is ideal to look at this process in patients who have only had one side of their neck treated and use the other side as a comparison. The study will also be looking for earlier signs of radiotherapy-related changes, such as stiffening of the artery wall, inflammation in the artery wall (a very early sign of radiotherapy-related change) and some markers in the blood that may indicate that this process is taking place.
The null hypotheses of this study are:
- In irradiated carotid arteries, the mean intimal-medial thickness will be the same compared to unirradiated arteries.
- Serum biomarkers will not be elevated in radiation-induced carotid atherosclerosis.
- Development of radiation-induced carotid atherosclerosis is not affected by risk factor modulation (Aspirin, HMGCoA reductase inhibitors, smoking cessation).
- There is no difference in carotid arterial wall strain in irradiated carotid arteries versus unirradiated carotid arteries.
- Microbubble ultrasound will not be able to detect Inflammation in the carotid arteries as an early marker of atherosclerosis.
Panoramica dello studio
Stato
Condizioni
Tipo di studio
Iscrizione (Effettivo)
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Be 18 years or older
- Histologically confirmed cancer or benign tumours of the head and neck area treated with hemi-neck radiotherapy to ≥ 50Gy
- Received radiotherapy to the neck area more than 24 months previously
- Intervening neck dissection allowed
- Be able to provide written informed consent
Exclusion Criteria:
- Patients who have active head and neck cancer
- Patients with a prior history of carotid endarterectomy or carotid angioplasty and stenting
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
|---|
|
Cross-sectional hemi-neck RT
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
The difference in mean IMT between irradiated and unirradiated carotid arteries.
Lasso di tempo: >2 years post-radiotherapy
|
Cross-sectional study - measured at one time-point at least 2 years after radiotherapy
|
>2 years post-radiotherapy
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
The prevalence of carotid artery stenosis in irradiated carotid arteries compared to unirradiated carotid arteries.
Lasso di tempo: >2 years post-radiotherapy
|
Cross-sectional - measured at one time point at least 2 years after radiotherapy
|
>2 years post-radiotherapy
|
|
Quantify the use of risk-modifying therapy (anti-hypertensives, anti-diabetic medication, HMGCoA reductase inhibitors, smoking cessation) and their effect on radiation-induced carotid atherosclerosis.
Lasso di tempo: > 2 years post-radiotherapy
|
Cross-sectional - measured at one time point at least 2 years after radiotherapy
|
> 2 years post-radiotherapy
|
|
Correlation of serum biomarker levels to carotid IMT and strain.
Lasso di tempo: > 2 years post-radiotherapy
|
Cross-sectional - measured at one time point at least 2 years after radiotherapy
|
> 2 years post-radiotherapy
|
|
The difference in arterial wall strain between irradiated and unirradiated carotid arteries
Lasso di tempo: > 2 years post-radiotherapy
|
Cross-sectional - measured at least 2 years after radiotherapy
|
> 2 years post-radiotherapy
|
|
The difference in arterial wall inflammation between irradiated and unirradiated carotid arteries
Lasso di tempo: > 2 years post-radiotherapy
|
Cross-sectional - measured at one time point at least 2 years after radiotherapy
|
> 2 years post-radiotherapy
|
Collaboratori e investigatori
Collaboratori
Investigatori
- Investigatore principale: Christopher M Nutting, PhD, Royal Marsden NHS Foundation Trust
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- CCR 3687
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .